Vesynta raises €275K Seed round

23 April 2024· London, United Kingdom· health, diagnostics, ai, biotech, b2b, software_hardware

The funding will be used to accelerate the development of Vesynta's core decision support platform, Dosologic, for use by 2025, and to drive commercial partnerships with drug developers to expand drug labels for special patient populations.

Investors

Leado2h Ventures

Also participating

SFC CapitalLifeArc VenturesBritish Patient CapitalLondon & PartnersUCL Technology FundKin Fund ServicesP4 Precision Medicine AcceleratorSPARK for Innovations in Pediatrics HubBioIndustry Association

About Vesynta

Stage

Seed

Headquarters

London, United Kingdom

Founded

2019

Team Size

6–20

Sectors

healthdiagnosticsaibiotechb2bsoftware_hardware

https://www.vesynta.com/

Source: https://o2hventures.com/an-seis-investment-in-vesynta-by-o2h-ventures-human-health-fund/